I'm hoping that with IBD involved, even a "heavier back end" deal will still have $50M-100M+ upfront. We need to clear off that $8M in liabilities and still have enough to show the markets that the war chest is solid for years to come.
As long as our funding is questionable or dependent upon the market in the short-medium term we are at the mercy of manipulators. There's too much on the line to continue with the shoe string budget in my opinion.
News 
Market Data 
Discover 
